Elizabeth E. Evans - 31 Mar 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role: Chief Operating Officer
Signature: /s/ Scott E. Royer, Attorney-in-Fact for Elizabeth E. Evans
Issuer symbol: VCNX
Transactions as of: 31 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 03 Apr 2023, 16:35:09 UTC
Previous filing: 04 Apr 2022
Next filing: 22 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VCNX	Common Stock						9,600	31 Mar 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCNX	Stock Option (Right to Buy)	Award	$0	+40,000		$0.000000	40,000	31 Mar 2023	Common Stock	40,000	$0.3995	Direct	F5
holding	VCNX	Stock Option (Right to Buy)						9,610	31 Mar 2023	Common Stock	9,610	$7.10	Direct	F1
holding	VCNX	Stock Option (Right to Buy)						8,605	31 Mar 2023	Common Stock	8,605	$7.10	Direct	F1
holding	VCNX	Stock Option (Right to Buy)						12,400	31 Mar 2023	Common Stock	12,400	$3.90	Direct	F1
holding	VCNX	Stock Option (Right to Buy)						10,000	31 Mar 2023	Common Stock	10,000	$3.82	Direct	F2
holding	VCNX	Stock Option (Right to Buy)						8,000	31 Mar 2023	Common Stock	8,000	$2.93	Direct	F3
holding	VCNX	Stock Option (Right to Buy)						20,000	31 Mar 2023	Common Stock	20,000	$1.29	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option is fully exercisable as of the date of this report.
F2	This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 3, 2020 grant date.
F3	This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
F4	This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
F5	This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date.